A statistically significant difference in efficacy favoring RPV/FTC/TDF was demonstrated for participants with baseline HIV-@ RNA @ copies/ml or less -LSB- ( n = @ ) @ % RPV/FTC/TDF vs. @ % EFV/FTC/TDF ( difference @ % , @ % CI @-@ @ % ) -RSB- .